Leveraging Brands for Investor Appeal
ENBREL
Client
Immunex Corporation
Description
Innovative biologic for the treatment of rheumatoid arthritis (RA)
Objective
Client seeks to increase their visibility and intrinsic value with physicians, patients and investors.
Branding Strategy
Create the first brand within a new class.
Reposition the entire RA category through this revolutionary class of drug.
Develop a highly differentiated brand name to distinguish the product from traditional pharma - communicate new science through a unique construction, and inspire patient hope and quality of life through an approachable and caring personality.
Tactics
Obtain extensive patient input
Develop key brand messages for maximal differentiation
Ensure involvement of opinion leaders and key influencers for direction and buy-in to class name
Announce and use brand and class names in all pre-marketing communications
Relevant GBS Services 
Branding Strategy Workshop
ClassNameSM
XtremeFocusSM